Verastem, Inc. (VSTM)
$6.86-0.44%Close
BUYRECOVERY · day 38
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $603M
- Avg volume
- 2.5M
- Beta
- 0.29
- P/E (TTM)
- -2.79
- Short % float
- 37.42%
- Days to cover
- 9.3
- SI change
- -1.4%
- 1W
- -4.46%
- 1M
- +13.39%
- 3M
- +61.79%
- YTD
- -5.12%
- vs SPY 1W
- -3.27%
- vs SPY 1M
- +10.07%
- vs SPY 3M
- +59.40%
- vs SPY YTD
- -16.87%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CYTKSELLCytokinetics, IncorporatedBEARQ 9$77.09+0.33%
- AKBASELLAkebia Therapeutics, Inc.CRISISQ -14$0.90-1.10%
- FEEDBUYENvue Medical, Inc.CRISISQ -17$0.40+2.56%
- SEERSELLSeer, Inc.RECOVERYQ -22$2.04+0.49%
- SPOKSELLSpok Holdings, Inc.RECOVERYQ 13$10.62+3.01%
- HOWLBUYWerewolf Therapeutics, Inc.RECOVERYQ -14$0.88+1.15%
- CSBRSELLChampions Oncology, Inc.CRISISQ 12$4.97+0.20%
- ACIUBUYAC Immune S.A.RECOVERYQ -2$2.86-1.38%
- TXMDSELLTherapeuticsMD, Inc.RECOVERYQ -2$2.07+0.49%
- BBIOSELLBridgeBio Pharma, Inc.RECOVERYQ 20$81.07-0.53%
- CDIOBUYCardio Diagnostics Holdings, Inc.CRISISQ -18$1.93-4.93%
- EVOBUYEvotec SECRISISQ 15$1.89-2.07%
Industry peers
FMP comparable companies · ranked by market cap
- ABSIBUYAbsci Corporation$1.5BCRISISQ 1$8.84-7.43%
- KALVBUYKalVista Pharmaceuticals, Inc.$1.4BBULLQ 9$27.00+0.00%
- MLTXSELLMoonLake Immunotherapeutics$1.3BCRISISQ 4$15.37-2.47%
- CRVSBUYCorvus Pharmaceuticals, Inc.$1.2BRECOVERYQ 14$14.09-2.56%
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- OLMASELLOlema Pharmaceuticals, Inc.$911MCRISISQ 1$10.43-2.43%
- FDMTBUY4D Molecular Therapeutics, Inc.$805MRECOVERYQ 5$15.39-2.78%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 2
- GROWTH
- 25
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-280.5%
REV YoY-
ROE-467.5%
EPS YoY-
ROA-98.2%
GROSS87
OP-183
NET-232
[VALUATION]
P/E TTM-2.79
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B13.74
P/FCF-
EV/EBITDA-2.76
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E168.71
ALTMAN Z-
CURR RATIO2.25
ND/EBITDA-
BETA0.29
